Paper · 75547
Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.
Russell JH and 3 others. Proc Natl Acad Sci U S A, 1978. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes. Papers, record 75547. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75547
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| H-2 Antigens | Major topic |
| Isoantibodies | Major topic |
| Multiple Myeloma | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antigen-Antibody Reactions | |
| Cytotoxicity, Immunologic | |
| Epitopes | |
| Female | |
| Male | |
| Mice | |
| Neoplasm Transplantation | |
| Neoplasms, Experimental | |
| Time Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,081,575 | In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. | J Exp Med | 1975 | https://conductscience.org/library/papers/1081575 | PubMed |
| 2 | 1,082,989 | T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2. | Nature | 1976 | https://conductscience.org/library/papers/1082989 | PubMed |
| 3 | 1,087,237 | In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes. | Eur J Immunol | 1976 | https://conductscience.org/library/papers/1087237 | PubMed |
| 4 | 182,884 | Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts. | J Immunol | 1976 | https://conductscience.org/library/papers/182884 | PubMed |
| 5 | 197,198 | Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas. | J Exp Med | 1977 | https://conductscience.org/library/papers/197198 | PubMed |
| 6 | 330,758 | Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation. | J Immunol | 1977 | https://conductscience.org/library/papers/330758 | PubMed |
| 7 | 402,006 | Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/402006 | PubMed |
| 8 | 4,267,212 | Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. | Nat New Biol | 1973 | https://conductscience.org/library/papers/4267212 | PubMed |
| 9 | 4,547,153 | Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. | Eur J Immunol | 1974 | https://conductscience.org/library/papers/4547153 | PubMed |
| 10 | 47,901 | H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;. | J Exp Med | 1975 | https://conductscience.org/library/papers/47901 | PubMed |
1 to 10 of 17
See all 17 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25,617,368 | Herman N. Eisen: Mentor to many. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25617368 | PubMed |
| 7,333,657 | Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K. | Immunogenetics | 1981 | https://conductscience.org/library/papers/7333657 | PubMed |
| 6,265,359 | Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles. | Infect Immun | 1981 | https://conductscience.org/library/papers/6265359 | PubMed |
| 6,255,476 | Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6255476 | PubMed |
| 6,162,788 | Dissociation of H-2 recognition by antibody and cytotoxic T cells of a cloned murine leukemia cell line. | Immunogenetics | 1981 | https://conductscience.org/library/papers/6162788 | PubMed |
| 204,941 | Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/204941 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75547
GET https://conductscience.org/api/papers/v1/75547/authors